Human mammary epithelial cells secrete and express on their cell surfaces complex mucin glycoproteins (Mr > 250,000) that are developmentally regulated, tumorassociated, and highly immunogenic. Studies using monoclonal antibodies directed to these glycoproteins suggest that their molecular structures can vary with differentiation stages in the normal gland and in malignancy. To analyze the molecular nature of these glycoproteins, milk mucin was affinity-purified and deglycosylated with hydrogen fluoride, yielding bands at 68 and 72 kDa on silver-stained gels. Polyclonal and monoclonal antibodies to the stripped core protein were developed and used to screen a Xgtll expression library of cDNA made from mRNA of the mammary tumor cell line MCF-7. Seven crossreacting clones were isolated, with inserts 0.1-1.8 kilobases long. RNA blot analysis, using as a probe the 1.8-kilobase insert subcloned in plasmid pUC8 (pMUC10), revealed transcripts of 4.7 and 6.4 kilobases in MCF-7 and T47D mammary tumor cells, whereas normal mammary epithelial cells from pooled milks have additional transcripts. The expression of mRNA correlates with antigen expression as determined by binding of two previously characterized anti-mucin monoclonal antibodies (HMFG-1 and HMFG-2) to seven cell lines. Restriction enzyme analysis detected a restriction fragment length polymorphism when human genomic DNA was digested with EcoRI or Hinfl.
tumor glycoproteins, although this is quantitative rather than qualitative. The molecules expressing the epitopes recognized by these antibodies have been difficult to analyze, both because they are large (>250 kDa) and heavily glycosylated and because of their complex pattern of expression. Use of two mAbs, HMFG-1 and HMFG-2 (originally called 1.10.F3 and 14.A.3, respectively; ref. 10) , has shown that the reactive component in human milk appears to be >400 kDa, while the molecules carrying the antigenic determinants in sera and tumors are smaller [but generally still >200 kDa (1)] and exhibit a genetic polymorphism (11) .
The large glycoprotein produced by the differentiated mammary epithelial cells and found in human milk or in the milk fat globule has been purified and shown to have features characteristic of mucins. This component, designated PAS-0 by Shimizu and Yamauchi (12) or EMA by Ormerod et al. (13) , contains a large amount of carbohydrate joined in O-linkage to serine and threonine residues. Moreover, the core protein contains high levels of serine, threonine, and proline and low levels of aromatic and sulfur-containing amino acids. Comparable data on the mucin produced by breast cancers are not available.
Because detection of the epithelial cell-specific mucins is used extensively in the diagnosis of carcinomas and in basic studies on differentiation and malignancy in epithelial cells, it is important to obtain information regarding their structure. Our approach to this problem has been to isolate cDNA clones coding for the core protein of a mucin expressed by a breast cancer cell line. Since many of the antibodies reactive with the intact mucin have been thought to recognize carbohydrate determinants, we have purified the milk mucin, stripped it of carbohydrate, and raised new antibodies reactive with the core protein (14) . A Xgtll expression library of cDNA made from the human mammary adenocarcinoma cell line MCF-7 (15) has been screened with these antibodies to the mucin core protein. Seven positive clones that code for the antigenic portion of the core protein were identified and characterized. Our results indicate that the milk mucin and the glycoproteins on breast cancer cells that share common epitopes also share the same core protein, which appears to be encoded by one polymorphic gene.
MATERIALS AND METHODS
Purification and Deglycosylation of Milk Mucin. mAb HMFG-1, purified from tissue culture supernatant by protein A affinity column chromatography (1), was coupled to cyanogen bromide-activated Sepharose (Pharmacia) as described in the manufacturer's instructions. Human skim milk was passed through the affinity column, followed by extensive washing with phosphate-buffered saline (153 mM NaCI/3 mM KCI/10 mM Na2HPO4/2 mM KH2PO4, pH 7.4). Bound antigen was eluted from the column with 0.1 M glycine (pH 2.5), and the fractions that absorbed at 280 nm were pooled, dialyzed against 0.25 M acetic acid, and lyophilized.
Affinity-purified mucin (about 20 mg) was dissolved in 0.25 M acetic acid and passed through a Sephadex G-75 column (1 X 100 cm) that had been equilibrated with 0.25 M acetic acid.
Abbreviation: mAb, monoclonal antibody.
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The column was washed with 0.25 M acetic acid and 1-ml fractions were collected. The material that was eluted in the void volume was lyophilized and the dry powder was stored at 40C. The purified milk mucin was treated with anhydrous hydrogen fluoride (16) for either 1 hr at 40C to produce a partially stripped mucin or for 3 hr at room temperature to produce an extensively stripped mucin.
The stripped and unstripped mucin preparations were electrophoresed in NaDodSO4/polyacrylamide gels (10% and 5-15%, respectively) and silver-stained by two methods, one of which can be used to stain highly glycosylated proteins (17, 18) .
Preparation of Polyclonal Rabbit Antiserum to Stripped Core Protein. One New Zealand White rabbit was immunized with 100 ,tg of the partially stripped core protein in complete Freund's adjuvant (GIBCO). Booster injections of 50 ,ug of the totally stripped core protein were administered in incomplete Freund's adjuvant (GIBCO) 3 and 4 weeks after the initial injection, and the rabbit was bled 1 week later. Ten microliters of immune serum (75 Ag of protein per ml) precipitated 200 ng of fully stripped core protein in a protein A assay (19) and detected it on immunoblots. The immunoglobulin fractions of rabbit preimmune serum and rabbit anti-mucin core protein antiserum were prepared by ammonium sulfate precipitation and stored in aliquots at -20'C.
mAbs. In addition to the polyclonal antiserum used for initial screening, a mixture of two mAbs, SM-3 and SM-4, which recognize the mucin core protein but not the fully glycosylated mucin (14) , and the individual mAbs HMFG-1 and HMFG-2 (1, 10) were used to screen the purified Xgtll plaques and the 8-galactosidase fusion proteins and for immunoprecipitations of in vitro translated proteins. Other mAbs used were a monoclonal anti-,B-galactosidase antibody, which was a gift from H. Durbin (Imperial Cancer Research Fund, London); ST254, an anti-interferon antibody (19) ; LE61, which reacts with keratin 18; and M18, which recognizes a carbohydrate structure on the milk mucin.
Antibody Screening of Xgtll Library and Protein Blotting. The Xgtll library was constructed from mRNA isolated from the human breast cancer cell line MCF-7 and was generously provided by S. Green and P. Chambon (Strasbourg, France). The poly(A)+ RNA used for the preparation of the randomly primed library was prepared from mRNA that sedimented faster than 28S rRNA and was enriched in estrogen receptor (15) .
The phage library was plated onto Escherichia coli Y1090 and screened essentially as described by Huynh et al. (20) . Initial screening was performed with the rabbit polyclonal antiserum (diluted 1:200 in phosphate-buffered saline containing 1% bovine serum albumin) raised against the stripped core protein. The nitrocellulose filters were washed in phosphate-buffered saline containing 1% bovine serum albumin, and bound antibody was detected by using horseradish peroxidase-conjugated sheep anti-rabbit immunoglobulin antiserum (Dako) diluted 1:500 and 4-chloro-1-naphthol (1) . Immunoreactive bacteriophage were picked and purified through two additional rounds of screening. Subsequently, bacteriophage inserts were subcloned into the EcoRI sites of plasmid pUC8 and maintained in E. coli DH1 cells.
RESULTS
Purification and Deglycosylation of Mucin Glycoprotein. Mucin glycoprotein reactive with mAb HMFG-1 was prepared from pooled human breast milk by using an HMFG-1 antibody affinity column followed by molecular-sieve chromatography on Sephadex G-75 to remove lower molecular weight components. Periodic acid/silver-stained gels revealed a diffuse band at Mr >400,000, which was detected only if the gel was treated with periodic acid prior to silver staining (Fig. 1A) . No other lower molecular weight bands were visualized when the gel was silver-stained without previous treatment with periodic acid. Amino acid analyses of four separate preparations of the purified mucin revealed a fairly consistent composition with serine, threonine, proline, alanine, and glycine accounting for 58% of the amino acids (data not shown).
The purified material was subjected to treatment with hydrogen fluoride to produce a partially deglycosylated core protein (treated at 00C for 1 hr) and a fully deglycosylated core protein (treated at room temperature for 3 hr) as determined by binding of radioiodinated lectin to protein blots. The hydrogen fluoride-treated mucin was fractionated by NaDodSO4/10% polyacrylamide gel electrophoresis. Silver staining showed that the predominant component of the partially stripped mucin was a high molecular weight species of Mr -400,000, although faint bands at lower molecular weight could also be observed (Fig. 1B, lane 1) . Since the high molecular weight material showed a somewhat increased mobility in the gel and increased reactivity with the lectin recognizing the linkage sugar (14) , it can be assumed that some sugars had been removed. The fully stripped mucin showed two predominant bands at Mr 68,000 and 72,000 ( Antibody-Reactive Proteins Produced by MCF-7 Cells. The MCF-7 breast cancer cell line expresses large amounts of HMFG-1-and -2-reactive material on its cell surface (10) and was thus judged to be a suitable source of mRNA for a cDNA library. Preliminary experiments in which MCF-7 poly(A)+ RNA was translated in vitro and immunoprecipitated with the mAbs HMFG-1, HMFG-2, SM-3, and SM-4 ( Fig. 2) To demonstrate that the reactivity of the phage clones with the antibody probes was due to antigenic determinants on the cDNA translation product, 3-galactosidase fusion proteins were made from all seven clones. The proteins were separated by electrophoresis, transferred to nitrocellulose paper, and probed with a variety of antibodies to the stripped mucin, including the polyclonal antiserum and a mixture of the mAbs SM-3 and SM-4 directed against the mucin core protein (14) . In addition, HMFG-1 and HMFG-2, the two mAbs that originally detected this differentiation-and tumor-associated epithelial mucin (1, 10), were tested. All seven clones yielded fusion proteins that were specifically recognized by mAb HMFG-2, as well as by polyclonal antiserum. The mAb HMFG-1 and the mixture of mAbs SM3 and SM4 reacted with six of the seven fusion proteins; these antibodies failed to recognize the protein from clone 9, which contains the smallest insert. In every case the strongest signal was given by the HMFG-2 antibody, and this reaction is shown in Fig.  3 . mAbs to keratins and to a carbohydrate epitope on this fully glycosylated mucin were used as controls and showed no reactivity (data not shown). A mAb toB-galactosidase was a positive control, and the band recognized correlated in every case with the band recognized by the specific antibod- 3 4 6 7 8 9 10 FIG. 3. Immunoblot analysis of fusion proteins from the XMUC clones. The phage clones XMUC3, -4, -6, -7, -8, -9, and -10 were used to lysogenize bacterial strain Y1089 as described by Huynh et al. (20) . Lysogen proteins were fractionated by NaDodSO4/polyacrylamide gel (7.5%) electrophoresis, transferred to nitrocellulose, and incubated with mAb HMFG-2 (1). Antibody binding was detected with an ELISA method using 4-chloro-1-naphthol as the substrate. Lane numbers are those of the XMUC clones.
ies. The sizes of the fusion proteins varied in proportion to the sizes of the cDNA inserts found in the bacteriophage.
The inserts from the A clones were'subcloned into the vector pUC8 for easier manipulation and designated pMUC3-10 (omitting pMUC5). The largest cDNA insert from pMUC10 was used to probe the other inserts and found to hybridize to all six (data not shown). pMUC7 was found to contain two inserts, following digestion with EcoRI; however, only one of the inserts hybridized to the pMUC10 probe. As shown by agarose gel electrophoresis, the'inserts varied from about 0.1 to about 1.8 kilobases (kb) in length. The largest insert from pMUC10 was used as the hybridization probe in all subsequent experiments.
Analysis of mRNA Expression in Various Cells Using the pMUC10 Probe. Additional evidence that the pMUC clones were indeed coding for the breast epithelial mucin was provided by correlating the presence of mRNA hybridizing to the pMUC1O clone with mucin expression in various cell lines, some of which expressed the mammary mucin and some of which did not. As shown in Fig. 4 , the cDNA hybridized to two transcripts of -4.7 kb and -6.4 kb in the RNA from the breast cancer cell lines MCF-7 and T47D, which were shown previously to express the HMFG-2 antigen (1, 10). Significantly, the pMUC10 probe hybridized to transcripts of similar size in RNA extracted from normal mammary epithelial cells cultured from milk (22) ; however, a third transcript (5.7 kb) could be detected in the RNA from these normal cells. The normal mammary epithelial cells were derived from pooled milk samples, and the additional transcript observed is likely to be due to polymorphisms among individuals. Transcripts of different sizes were observed in other samples of pooled human milks (data not shown). In both normal and malignant breast epithelial cells, the 6.4-kb band appeared to be the most abundantly expressed. In contrast to the above observations, three human cell types that lack the mucin-embryonic fibroblasts, Daudi (Burkitt lymphoma) cells, and Hs578T, a carcinosarcoma line derived from breast tissue-showed no detectable pMUC10-related mRNA. Analysis of Genomic DNA and Detection of a Restriction Frment Length Polymorphism. Genomic DNA was prepared from a panel of 10 individuals, consisting of six unrelated individuals and a family of four, and from three cell lines. The DNA samples were digested with Hinfl or EcoRI, blotted, and hybridized to the radiolabeled pMUC10 insert (Fig. 5) . Restriction fragment length polymorphisms were detected. The pattern consists of either a single band or a doublet corresponding to lengths ranging from 3. (21), blotted onto nitrocellulose, and hybridized as described by Thomas (23) . The hybridization probe was the pMUC10 EcoRI insert, which was labeled with [a-32P]dCTP by the method of random priming (24) . Filters were washed down to O.lx SSC/0.1% NaDodSO4 (lx SSC is 150 mM NaCI/15 mM sodium citrate, pH 7) at 65°C and exposed to XAR-5 film (Kodak) for 18 hr at -70°C with intensifying screens. Transcript sizes (at left in kb) were estimated by comparison with 28S (5.4-kb) and 18S (2.1-kb) rRNAs.
shows three bands) or from 8.2 to 9.6 kb in the EcoRI digest (Fig. 5 Right) . There appears to be a continuous distribution of the fragment sizes, which implies a high in vivo instability at the locus. The pattern of fragments observed in the family of four (lanes 1-4) suggests that these fragments are allelic.
DISCUSSION
The cDNA clones described here were selected from the MCF-7 Xgtll library by screening with polyclonal and monoclonal antibodies prepared against a modified normal cellular product, the milk mucin in its deglycosylated form. This was done because it was easier to obtain large quantities of the mucin for stripping than to prepare similar quantities of Hinf I 1 2 3 4 5 6 7 8 9 10 11 1213 0 I immunologically related glycoproteins expressed by breast cancer cells. The fact that the polyclonal and monoclonal antibodies to the milk mucin core protein did select for cDNA coding for nonglycosylated core protein molecules in MCF-7 cells strongly suggests that the glycoproteins in these cells, which are immunologically related to milk mucin, contain the same core protein as this mucin. This is confirmed by the detection of mRNAs of approximately the same sizes in both the normal and the malignant cells, using one of the probes isolated from the MCF-7 library. We will therefore refer to the antibody-reactive glycoproteins on breast cancer cells as mucins, bearing in mind that their processing may be different, resulting in molecules of different molecular weights but with the same core protein as that of milk mucin.
Seven clones were obtained from the MCF-7 library; the largest (1.8 kb) cross-hybridized with the six smaller clones. The 3-galactosidase fusion proteins expressed by six of the cross-hybridizing X clones were reactive with the polyclonal antiserum as well as with four well-characterized mAbs directed to various epitopes on the stripped core protein, SM-3, SM-4, HMFG-1, and HMFG-2 (14) . The smallest X clone, XMUC9, produced a 8-galactosidase fusion protein that reacted with HMFG-2 and with the polyclonal antiserum.
That the antibodies HMFG-1 and HMFG-2, which react with the unstripped milk mucin, also reacted strongly with the X plaques and the fusion proteins and could immunoprecipitate proteins from in vitro translated mRNA provides strong evidence that these clones do indeed code for a portion of the mucin core protein. Both HMFG-1 and HMFG-2 react strongly with the fully stripped iodinated core protein (14) . Thus, although previous evidence, such as resistance to fixation, boiling, or treatment with dithiothreitol and NaDod-S04 and the presence of multiple epitopes on the molecule, suggested that these were carbohydrate (1), it has now been established that the epitopes recognized by the HMFG-1 and HMFG-2 mAbs are definitely protein in nature. Carbohydrate may be required to obtain the strongest binding, either as part of the epitope or by conferring some conformational change on the protein portion, but part of the antigenic determinant must consist of an amino acid sequence. Since EcoR I 1 2 3 4 5 6 7 8 9 10 11 (25) . Preliminary sequence data (unpublished) suggest that the basis for this polymorphism is a region of variable tandem repeats present in the protein-coding sequences, and the similarity in the patterns obtained by restriction digests with two different enzymes is in agreement with this interpretation. This structural feature may be responsible for the extensive generation of allelic restriction fragments at the mucin locus. Similar polymorphisms caused by the presence of variable tandem repeats in human genes have been observed in either flanking sequences or introns associated with the c-Ha-ras, insulin, myoglobin, and aglobin genes (26) (27) (28) (29) , and tandem repeats are responsible for the polymorphisms identified by the minisatellite probes described by Jeffreys et al. (30) .
The availability of a partial cDNA clone for the core protein of mammary mucin has allowed us to identify a polymorphic gene whose expression is regulated by tissuespecific factors. That the gene is consistently expressed in breast cancers means that it will be important to study the regulation of its expression in these tumors as well as ih normal differentiation. It will also be important to examine DNA preparations from the leukocytes and tumors of individual breast cancer patients to determine if there is any discordance between genotype in the paired samples, since tandemly repeated DNA may provide an unstable site where recombination or amplification could occur.
